ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

PORTLAND, Maine, May 14, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (the “Company” or “ImmuCell”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced a change in the location of its 2020 Annual Meeting of Stockholders. In light of the COVID-19 pandemic and in an effort to protect the health and safety of the Company’s stockholders, employees and communities, the Annual Meeting will be held by remote communication in the form of both a dial-in conference call and an audio webcast rather than an in-person event.

The Annual Meeting will take place Wednesday, June 10, 2020, at 3:00 PM ET, as previously announced. Stockholders of record of the Company’s common stock at the close of business on Tuesday, April 14, 2020, are invited to participate in the Annual Meeting by dialing 844-855-9502. Dial-in participants will have access to the Question and Answer session that will take place after the formal business of the meeting is concluded and after a review of its Corporate Presentation slide deck, which is available now on the Company’s website. The Company will also provide access to the Annual Meeting via an “audio webcast” that can be accessed at: https://www.webcaster4.com/Webcast/Page/1214/34878. Audio webcast participants will not have the ability to ask questions during the Question and Answer session.

Stockholders, regardless of their plans to attend the virtual-only meeting, are encouraged to vote and submit their proxies in advance of the Annual Meeting using one of the methods described in the proxy materials. Stockholders may continue to use the voting instruction form or proxy card provided, and no additional action is required to be taken by stockholders who have already submitted their proxy. Stockholders that would like to vote at the Annual Meeting (instead of by proxy) should contact the Company (Beth Toothaker at [phone] Ext. 3103 or [e-mail]) to arrange for voting during the meeting.

For more information about the Annual Meeting, including the matters to be voted on during the Annual Meeting, please see the Company’s Notice of Annual Meeting of Stockholders and its Proxy Statement, which are available, along with the 2019 Annual Report on Form 10-K, at www.immucell.com.
             
Conference Call:
Interested parties can access a conference call scheduled by the Company to review the first quarter 2020 financial results by dialing [phone] (toll free) or [phone] (international) at 9:00 AM ET on Thursday, May 14, 2020.  A teleconference replay of the call will be available for seven days at [phone] (toll free) or [phone] (international), utilizing confirmation #10143957. Investors are encouraged to review the Company’s Form 10-Q for the three-month period ended March 31, 2020 that will be filed with the SEC after the market closes on May 13, 2020 and its updated Corporate Presentation slide deck that provides an overview of the Company’s business and is available under the “Investors” tab of the Company’s website at www.immucell.com, or by request to the Company.